Immunotherapy and Prostate Cancer

Immunotherapy expert Dr. David Oh explains how the immune system can be trained to recognize and fight prostate cancer. He outlines key immune players—dendritic cells and T cells—and describes how immunotherapies target different stages of their interaction with tumors. Oh highlights FDA-approved treatments such as Provenge, a vaccine made from a patient’s own cells, and PD-1 checkpoint inhibitors for patients with specific genetic mutations like microsatellite instability. He also discusses potential autoimmune side effects and emphasizes the importance of genetic testing. Looking ahead, he introduces bispecific T-cell engagers, experimental therapies that physically link T cells to tumors, triggering an immune attack. These promising treatments offer new hope, especially for men with advanced, treatment-resistant prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40811]

You can listen to Immunotherapy and Prostate Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

Immunotherapy and Prostate Cancer is an episode from Winning the War on Cancer (Audio) by UCTV.

This episode is 00:11:08 long.

This episode was published on Aug 21, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Winning the War on Cancer (Audio) when more episodes are available from the podcast feed.